A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes
Authors:
- L. Douglas RiedLRL. Douglas Ried
- Gary E. KleinGKGary E. Klein
- Wendy MyersWMWendy Myers
- Kristen FoliKFKristen Foli
- 1 March 2009
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 49 (2) , 192-199
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Development and testing of performance measures for pharmacy servicesJournal of the American Pharmacists Association, 2009
- Switching Statin Therapy Using a Pharmacist‐Managed Therapeutic Conversion Program versus Usual Care Conversion Among Indigent PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Medication therapy management in pharmacy practice: Core elements of an MTM service model (version 2.0)Journal of the American Pharmacists Association, 2008
- Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organizationAmerican Journal of Health-System Pharmacy, 2007
- Patient Self-Management Program for Diabetes: First-Year Clinical, Humanistic, and Economic OutcomesJournal of the American Pharmacists Association, 2005
- Achieving Cholesterol Target in a Managed Care Organization (ACTION) TrialPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Assessment of Clinical Pharmacist Management of Lipid-Lowering Therapy in a Primary Care SettingJournal of Managed Care Pharmacy, 2003